Pathway Therapeutics pathwaytx.com


Public lists: Pharma Startups (4740)

Pathway Therapeutics is a clinical stage, privately held, pharmaceutical company developing differentiated isoform specific PI3-kinase (PI3K) inhibitors for oncology, inflammatory and respiratory diseases. The company's lead product, PWT33597, is a balanced, dual PI3K alpha/mTOR inhibitor and the first compound with this profile to enter the clinic. Dual inhibition of PI3K and mTOR shuts down the PI3K/mTOR pathway more effectively than single target inhibitors. Of the four PI3K isoforms, PI3K...Show all

Pathway Therapeutics is a clinical stage, privately held, pharmaceutical company developing differentiated isoform specific PI3-kinase (PI3K) inhibitors for oncology, inflammatory and respiratory diseases. The company's lead product, PWT33597, is ...Show all

Company (Alive / Active)

Phone: 415-643-4473

Fax:

409 Illinois Street

San Francisco, 94158
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Pathway Therapeutics $24.9M Nov 30, 2012

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Pathway Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
GBS Venture PartnersVenture CapitalAustraliaDebt, Series B, Series A - IV, Series A - III, Series A
CM CapitalVenture CapitalAustraliaDebt, Series B, Series A - IV, Series A - III, Series A
Trans Tasman Commercialisation FundAcademic/UniversityAustraliaSeries A - IV, Series A - II
New Zealand Venture Investment FundVenture CapitalAuckland, New ZealandSeries A - IV
Breast Cancer Research TrustNon-Profit FoundationNew ZealandDebt, Series B, Series A - IV
See all 5 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)